TEKMIRA PHARM
TEKMIRA PHARM operates in Diversified Metals & Mining.
TEKMIRA PHARM (I9DN) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2024: -0.194x
Based on the latest financial reports, TEKMIRA PHARM (I9DN) has a cash flow conversion efficiency ratio of -0.194x as of September 2024.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-20.74 Million) by net assets (€106.89 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
TEKMIRA PHARM - Cash Flow Conversion Efficiency Trend (2016–2023)
This chart illustrates how TEKMIRA PHARM's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
TEKMIRA PHARM Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of TEKMIRA PHARM ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Hemlo Mining Corp.
V:HMMC
|
N/A |
|
A-Labs Capital II Corp
V:ALAB-P
|
0.002x |
|
WEATHERF INT REG.
F:WH4
|
0.001x |
|
VIVA3F
SA:VIVA3F
|
N/A |
|
Assetco Plc
LSE:ASTO
|
-0.229x |
|
OMNIA HOLD
BE:OHZ
|
N/A |
|
Metals Exploration Plc
LSE:MTL
|
0.157x |
|
American Commerce Solutions Inc
PINK:AACS
|
-0.011x |
Annual Cash Flow Conversion Efficiency for TEKMIRA PHARM (2016–2023)
The table below shows the annual cash flow conversion efficiency of TEKMIRA PHARM from 2016 to 2023.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2023-12-31 | €106.02 Million | €-85.94 Million | -0.811x | -213.75% |
| 2022-12-31 | €136.85 Million | €-35.36 Million | -0.258x | +35.18% |
| 2021-12-31 | €169.44 Million | €-67.53 Million | -0.399x | +21.00% |
| 2020-12-31 | €101.97 Million | €-51.44 Million | -0.504x | +48.32% |
| 2019-12-31 | €72.74 Million | €-71.01 Million | -0.976x | -187.99% |
| 2018-12-31 | €200.23 Million | €-67.87 Million | -0.339x | -27.15% |
| 2017-12-31 | €182.47 Million | €-48.64 Million | -0.267x | +6.52% |
| 2016-12-31 | €203.00 Million | €-57.88 Million | -0.285x | -- |